DiaSorin revenue and financials
€77.90Change from previous close: +1.25%Absolute change: +€0.96
In the fiscal year ended December 2025, DiaSorin reported revenue of €1.2B (+0.81% year over year). Net income was €155.62M, a net margin of 13.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +0.81%
- 2025 vs 2024
- Net income growth
- −17.27%
- 2025 vs 2024
- Net margin
- 13.0%
- 2024: 15.9%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Total assets | 2,895 | 2,868 | — |
| Current assets | 752 | 760 | 359 |
| Cash and equivalents | 121 | 173 | — |
| Short-term investments | 0.1 | 1.3 | — |
| Inventory | 369 | 328 | — |
| Net property, plant and equipment | 272 | 256 | 267 |
| Goodwill | 780 | 756 | — |
| Other intangible assets | 1,047 | 972 | — |
| Long-term investments | 0.0 | 0.0 | — |
| Current liabilities | 421 | 555 | — |
| Accounts payable | 110 | 101 | — |
| Long-term debt | 731 | 472 | 672 |
| Total debt | 959 | 769 | 672 |
| Total liabilities | 1,479 | 1,336 | — |
| Total equity (incl. minority) | 1,416 | 1,532 | 1,684 |
| Retained earnings | 84.4 | 99.4 | — |
| Minority interest | -7.8 | -2.4 | — |